Items tagged with Access
As patients wait, WHO members chip away at decision on medical R&D funding (post)
09/05/2016 - A number of World Health Organization member states attended a meeting last week aimed finding ways to sustainably finance research and development for medical products, especially those for poor populations lacking means to pay high prices. According to the outcome document and a WHO official, they heard many viewpoints from experts and made progress but much was left for the World Health Assembly later this month.
Children with tuberculosis in India suffer on lack of proper fixed-dose combinations (post)
Since 2010, evidence is emerging that doses to treat TB earlier thought to be optimal are less than what a child’s body needs, doctors say
Public health advocates urge WHO action on alternative R&D financing (post)
Public health advocates last week told World Health Organization delegates they must act quickly to save the lives of poor populations suffering from less common diseases for which there is no research and development funding. Nongovernmental organisations showed up to a WHO meeting on the issue to urge on delegates, even holding a public demonstration in front of the UN, but there was concern afterward at the little progress made.
EU eyes revamp of policy to speed drug approvals in developing countries (post)
Article 58, a process introduced by the European Commission to help speed up the time low and middle-income countries take to approve new drugs, could be in for a massive overhaul.
U.S.:17 essential drugs at risk for price boost, analysts say (post)
Access is dwindling for many older, off-patent, essential drugs as companies use an emerging strategy to acquire therapies in niche markets where there are few or no alternatives, and then jack up the price.
India: TB patients protest outside health ministry, promised proper drug regimes from July (post)
May 20, 2016 - A group of tuberculosis patients, protesting outside the Union health ministry in Delhi's searing mid-May heat, brought attention to the problem of India's outdated tuberculosis treatment, and forced the ministry officials to give assurance to provide patients with the fixed-dose combination (FDCs) medicines they urgently need.
Mumbai: Hope for multidrug-resistant TB patients (post)
Such patients will be getting treated with bedaquiline drug and their samples have been sent for testing to ensure that they are physically fit to be administered with the drug.
Shift in discussions about R&D at this week’s World Health Assembly (post)
May 26, 2016 - Public health advocates – and many nations – had high hopes that this year’s World Health Assembly could finally agree on some alternative ways to fund research and development that can lead to affordable medical products by de-linking R&D costs from prices, through the long-awaited discussion of a landmark 2012 report of a WHO expert group on medical R&D. This week, that discussion has spread across the highest profile topics of the week such as antimicrobial resistance and emergencies, but some are concerned that the public health safeguards recommended by the expert group may be being left behind.
MSF calls on G7 leaders to urgently address the critical gaps in global response to public health emergencies and unite to lower the price of live-saving medicines (post)
Ise-Shima, Japan/Geneva May 26, 2016 - Two years since the first signs of the West Africa Ebola outbreak, the world today is little more prepared to respond to such an emergency than it was then, warns international humanitarian aid organisation Médecins Sans Frontières (MSF), while the lack of R&D into needed medicines and exorbitant medicine prices requires urgent and united action from the world leaders gathered in Japan.
WHO takes first step towards de-linking drug prices from access and innovation issues (post)
The World Health Organisation (WHO) will establish an expert technical committee that will help countries set health priorities as well as a global observatory that identifies gaps in health research and development (R&D), especially for diseases that disproportionately affect developing countries and attract little investment.
Page 21 of 83 · Total posts: 0
←First 20 21 22 Last→